Generation of a Conditionally Replicating Adenovirus Based on Targeted Destruction of E1A mRNA by a Cell Type-Specific MicroRNA

被引:99
作者
Ylosmaki, Erkko [1 ]
Hakkarainen, Tanja [2 ,3 ,4 ]
Hemminki, Akseli [2 ,3 ,4 ]
Visakorpi, Tapio [5 ,6 ]
Andino, Raul [7 ]
Saksela, Kalle [1 ]
机构
[1] Univ Helsinki, Dept Virol, Haartman Inst, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, HUSLAB, FIN-00014 Helsinki, Finland
[3] Univ Helsinki, Canc Gene Therapy Grp, Mol Canc Biol Program, FIN-00014 Helsinki, Finland
[4] Univ Helsinki, Transplantat Lab, FIN-00014 Helsinki, Finland
[5] Inst Med Technol, FIN-33014 Tampere, Finland
[6] Univ Tampere, Tampere Univ Hosp, FIN-33014 Tampere, Finland
[7] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
基金
芬兰科学院;
关键词
D O I
10.1128/JVI.01608-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
MicroRNAs have emerged as important players in tissue-specific mammalian gene regulation and have also been exploited in experimental targeting of gene expression. We have constructed a recombinant adenovirus that contains sequences complementary to the liver-specific microRNA 122 ( miR122) in the 3' untranslated region of the E1A gene. In Huh7 cells, which resemble normal hepatocytes in expressing high levels of miR122, this feature resulted in strongly reduced levels of E1A mRNA and protein. This property allowed us to generate a novel recombinant adenovirus that was severely attenuated in cells of hepatic origin but replicated normally in other cells. This strategy may be useful in circumventing liver toxicity associated with the systemic delivery of oncolytic adenoviruses. These data provide the first example of exploiting differential microRNA expression patterns to alter the natural tropism of a DNA virus. In addition, these results suggest that other microRNAs expressed in a tissue- or transformation-specific manner may also be used for the targeting of adenoviral replication and that the same principle may be applied to other viruses that have shown promise as oncolytic or gene delivery platforms.
引用
收藏
页码:11009 / 11015
页数:7
相关论文
共 46 条
[1]   Oncolytic viral therapies - the clinical experience [J].
Aghi, M ;
Martuza, RL .
ONCOGENE, 2005, 24 (52) :7802-7816
[2]   A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P-MAPK-selective mRNA stabilization [J].
Ahmed, A ;
Thompson, J ;
Emiliusen, L ;
Murphy, S ;
Beauchamp, RD ;
Suzuki, K ;
Alemany, R ;
Harrington, K ;
Vile, RG .
NATURE BIOTECHNOLOGY, 2003, 21 (07) :771-777
[3]   Cancer selective adenoviruses [J].
Alemany, Ramon .
MOLECULAR ASPECTS OF MEDICINE, 2007, 28 (01) :42-58
[4]   MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing [J].
Ambros, V .
CELL, 2003, 113 (06) :673-676
[5]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[6]   Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells [J].
Bauerschmitz, Gerd J. ;
Guse, Kilian ;
Kanerva, Anna ;
Menzel, Artur ;
Herrmann, Isabell ;
Desmond, Renee A. ;
Yamamoto, Masato ;
Nettelbeck, Dirk M. ;
Hakkarainen, Tanja ;
Dall, Peter ;
Curiel, David T. ;
Hemminki, Akseli .
MOLECULAR THERAPY, 2006, 14 (02) :164-174
[7]   An adenovirus mutant that replicates selectively in p53-deficient human tumor cells [J].
Bischoff, JR ;
Kim, DH ;
Williams, A ;
Heise, C ;
Horn, S ;
Muna, M ;
Ng, L ;
Nye, JA ;
SampsonJohannes, A ;
Fattaey, A ;
McCormick, F .
SCIENCE, 1996, 274 (5286) :373-376
[8]   MiRNAs in cancer: approaches, aetiology, diagnostics and therapy [J].
Blenkiron, Cherie ;
Miska, Eric A. .
HUMAN MOLECULAR GENETICS, 2007, 16 :R106-R113
[9]   Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state [J].
Brown, Brian D. ;
Gentner, Bernhard ;
Cantore, Alessio ;
Colleoni, Silvia ;
Amendola, Mario ;
Zingale, Anna ;
Baccarini, Alessia ;
Lazzari, Giovanna ;
Galli, Cesare ;
Naldini, Luigi .
NATURE BIOTECHNOLOGY, 2007, 25 (12) :1457-1467
[10]   Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates [J].
Brunetti-Pierri, N ;
Palmer, DJ ;
Beaudet, AL ;
Carey, KD ;
Finegold, M ;
Ng, P .
HUMAN GENE THERAPY, 2004, 15 (01) :35-46